Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Oil Slumps as New COVID-19 Virus Strain Pumps Fuel Demand Worries

Published 12/20/2020, 10:46 PM
Updated 12/20/2020, 10:49 PM
© Reuters.

By Gina Lee

Investing.com – Oil was down on Monday morning in Asia, slumping over the discovery of a new COVID-19 strain in the U.K. which could stall a nascent recovery in fuel demand and the global economy in general as tighter restrictions are introduced.

Brent oil futures slumped 3.20% to $50.59 by 10:45 PM ET (3:45 AM GMT) and WTI futures fell 3.09% to $47.72. WTI futures rolled over to the Feb 21 contract on Dec. 20. “A new variant of the coronavirus in Britain and tighter travel restrictions in Europe sparked fears over slower economic recovery, prompting investors to unwind long positions … the oil market has been on a bull trend in the past month or so, ignoring negative factors, amid an optimism that a widening vaccine rollout would revive global growth, but investors’ rosy expectations for 2021 have suddenly vanished,” Fujitomi Co. chief analyst Kazuhiko Saito told Reuters.

The variant, which is reportedly 70% more transmissible than the original strain of the virus, has also prompted concerns about a wider spread. Countries including France, Germany, Italy, the Netherlands, Ireland, Canada, Argentina and Chile have banned travelers from U.K., with some also banning freight. Other countries are considering similar bans.

U.K. Prime Minister Boris Johnson will chair an emergency response meeting later in the day to discuss international travel, with freight in and out of the country of particular concern. The country is also negotiating a post-Brexit trade deal with the European Union.

News of the new COVID-19 strain overshadowed the deal reached in the U.S. Congress for a $900 billion COVID-19 bill. The House of Representatives will vote on the bill later in the day, followed by the Senate.

Oil prices had marked seven straight weeks of gains last week as investors focused on the rollout of COVID-19 vaccines. On that front, the Food and Drug Administration also granted emergency use approval for Moderna Inc's (NASDAQ:MRNA) vaccine mRNA-1273 over the weekend, following the earlier approval for Pfizer Inc (NYSE:PFE) and BioNTech SE's (F:22UAy) vaccine BNT162b2.

Prices were also under pressure after the oil and gas rig count rose by eight to 346 in the week to Dec. 18 on Friday, its highest since May, according to Baker Hughes. The count was an indication that producers are continuing to return to the wellpad.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.